US Representative
Daniel Meuser 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 12)
Legislative Session
Primary Sponsor of Legislation
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB4625
Introduced
7/13/23
Refer
7/13/23
Protecting U.S. Business Sovereignty Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB4653
Introduced
7/14/23
Refer
7/14/23
Protecting U.S. Business Sovereignty Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB474
Introduced
1/24/23
Refer
1/24/23
Require Employees To Uniformly Return Now Act or the RETURN Act This bill prohibits Internal Revenue Service (IRS) employees from teleworking during the period beginning five business days after the enactment of this bill and ending on the date on which the IRS certifies that the processing backlog for income tax returns for all taxable years has been eliminated. The Department of the Treasury may not obligate additional funds for the IRS until the date on which the IRS certifies that the backlog has been eliminated.
Co-Sponsor of Legislation
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB467
Introduced
1/24/23
Refer
1/24/23
Refer
1/24/23
Report Pass
3/24/23
Engrossed
5/30/23
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB4671
Introduced
7/17/23
Refer
7/17/23
Report Pass
7/18/23
Corrective Action Report Oversight and Accountability Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB468
Introduced
1/24/23
Refer
1/24/23
Refer
2/3/23
Building America's Health Care Workforce Act This bill extends certain flexibilities relating to training and competency requirements for nurse aides in Medicare skilled nursing facilities (SNFs) and Medicaid nursing facilities (NFs). Generally, SNFs and NFs may not hire nurse aides for longer than four months unless they meet certain training and certification requirements. The Centers for Medicare & Medicaid Services waived some of these requirements during the COVID-19 emergency period so as to allow facilities to maintain adequate staffing levels; the blanket waiver ended in June 2022, though individual facilities, states, and counties may continue to apply for waivers during the emergency period. The bill extends these flexibilities for at least two years after the bill's enactment and specifies that (1) any time worked by a nurse aide during the emergency period counts toward the 75 hours required for initial training, and (2) a competency evaluation may be conducted at the SNF or NF where the nurse aide is employed if the state does not offer such an evaluation at least once a week.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB4708
Introduced
7/18/23
Refer
7/18/23
H–2 Improvements to Relieve Employers Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB4709
Introduced
7/18/23
Refer
7/18/23
U.S.-Israel Anti-Killer Drone Act of 2023
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB4721
Introduced
7/18/23
Refer
7/18/23
Main Street Tax Certainty Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB4758
Introduced
7/19/23
Refer
7/19/23
Refer
7/21/23
Report Pass
6/12/24
Engrossed
9/18/24
Accelerating Kids’ Access to Care Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB4776
Introduced
7/20/23
Refer
7/20/23
Refer
7/20/23
Protecting Free Speech Act
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB4790
Introduced
7/20/23
Refer
7/20/23
Report Pass
7/27/23
Engrossed
9/23/24
Protecting Americans’ Retirement Savings from Politics Act Businesses Over Activists Act Guiding Uniform and Responsible Disclosure Requirements and Information Limits Act of 2023 American FIRST Act of 2023 American Financial Institution Regulatory Sovereignty and Transparency Act of 2023
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB4803
Introduced
7/20/23
Refer
7/20/23
Personalized Care Act of 2023
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB484
Introduced
1/24/23
Refer
1/24/23
Refer
1/24/23
Natural Gas Tax Repeal Act This bill eliminates a program administered by the Environmental Protection Agency (EPA) that provides incentives for petroleum and natural gas systems to reduce their emissions of methane and other greenhouse gases. It also repeals a charge on methane emissions from specific types of facilities that are required to report their greenhouse gas emissions to the EPA's Greenhouse Gas Emissions Reporting Program.
US
Us Congress 2023-2024 Regular Session
Us Congress House Bill HB4860
Introduced
7/25/23
Refer
7/25/23
PROTECT the Second Amendment Act Preserving Rights Of Tenants by Ensuring Compliance To the Second Amendment Act